申请人:Bayer Schering Pharma Aktiengesellschaft
公开号:EP1964834A1
公开(公告)日:2008-09-03
The present invention relates to sulfonyltryptophanols of the general formula I,
in which Q, X, W, R1, R2, R3, R4, R5, R6, R7 and R8 have the meaning as defined in the description.
The compounds according to the invention are effective FSH receptor antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.
本发明涉及通式I的磺酰色氨酸醇类化合物,其中Q、X、W、R1、R2、R3、R4、R5、R6、R7和R8的含义如描述中所定义。根据本发明的化合物是有效的FSH受体拮抗剂,可用于男性或女性的生育控制,以及骨质疏松症的预防和/或治疗。